The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Passage Bio, Inc(NASDAQ:PASG)


Passage Bio, Inc., a genetic medicines company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid b...
Website: http://www.passagebio.com
Founded: 2017
Full Time Employees: 20
CEO: Bruce A. Goldsmith
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Passage Bio Days Payable Outstanding ttm (DPO)
Passage Bio Op Cashflow Per Share ttm
Passage Bio Free Cashflow Per Share ttm
Passage Bio Cash Per Share ttm
Passage Bio (GAAP) P/E ratio ttm
Passage Bio P/B ratio ttm
No extra charts and metrics for this ticker.